American Medical Association releases independent COVID, flu vaccine recommendations
The two medical groups released evidence reviews for the vaccines targeting COVID-19, respiratory syncytial virus (RSV) and the flu.
The American Medical Association and the Vaccine Integrity Project released their own guidelines on Thursday for the upcoming 2026-27 respiratory viral season based on their independent evidence review of existing data.
The two medical groups released evidence reviews for the vaccines targeting COVID-19, respiratory syncytial virus (RSV) and the flu.
The AMA’s recommendations are that all children 6 months and older receive the flu vaccine; babies and toddlers aged 6-23 months receive the COVID-19 vaccine and children 2-18 years old get the shot if they’re in certain risk groups, and all children 8 months and younger get the RSV shot if they did not receive protection before birth.
“The newest evidence continues to demonstrate that immunization provides meaningful protection against hospitalization, severe illness and death," the organizations said in its key findings. "The degree of protection varies by virus, vaccine or immunization product, population, season and circulating strains.
“No new safety concerns were identified in comparative studies evaluating currently recommended immunizations," they continued. "The findings are consistent with the well-established safety profiles of influenza and COVID-19 vaccines and the growing safety evidence for RSV immunizations."
Misty Severi is a news reporter for Just The News. You can follow her on X for more coverage.